Jump Financial LLC Boosts Stock Holdings in Bruker Corporation $BRKR

Key Points

• Jump Financial LLC significantly increased its stake in Bruker Corporation by acquiring an additional 139,317 shares, bringing its total ownership to 173,545 shares valued at approximately $7.24 million.
• Several hedge funds made substantial adjustments to their positions in Bruker during the first quarter, with institutional investors now holding 79.52% of the company's stock.
• Bruker reported a missed earnings estimate in its latest quarterly results, with EPS at $0.32 compared to an expected $0.33, and is setting FY 2025 guidance at 1.950-2.050 EPS.

Jump Financial LLC increased its holdings in shares of Bruker Corporation (NASDAQ:BRKR - Free Report) by 407.0% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 173,545 shares of the medical research company's stock after buying an additional 139,317 shares during the period. Jump Financial LLC owned about 0.11% of Bruker worth $7,244,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Pinnacle Bancorp Inc. acquired a new stake in Bruker during the 1st quarter worth approximately $29,000. Allworth Financial LP boosted its position in Bruker by 92.4% during the 1st quarter. Allworth Financial LP now owns 758 shares of the medical research company's stock worth $30,000 after buying an additional 364 shares during the period. Caitong International Asset Management Co. Ltd raised its holdings in Bruker by 1,354.5% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 800 shares of the medical research company's stock worth $33,000 after purchasing an additional 745 shares during the last quarter. Annis Gardner Whiting Capital Advisors LLC bought a new position in Bruker during the 1st quarter worth approximately $42,000. Finally, MassMutual Private Wealth & Trust FSB raised its holdings in Bruker by 274.9% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 1,091 shares of the medical research company's stock worth $46,000 after purchasing an additional 800 shares during the last quarter. 79.52% of the stock is currently owned by institutional investors and hedge funds.

Bruker Stock Up 1.6%

BRKR stock traded up $0.52 during midday trading on Friday, reaching $33.98. 1,844,597 shares of the company's stock traded hands, compared to its average volume of 3,265,055. The company has a market cap of $5.16 billion, a price-to-earnings ratio of 65.35, a P/E/G ratio of 2.79 and a beta of 1.16. The firm's fifty day moving average price is $38.04 and its 200-day moving average price is $40.27. The company has a quick ratio of 0.70, a current ratio of 1.61 and a debt-to-equity ratio of 1.31. Bruker Corporation has a 52 week low of $30.00 and a 52 week high of $72.94.

Bruker (NASDAQ:BRKR - Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The medical research company reported $0.32 EPS for the quarter, missing analysts' consensus estimates of $0.33 by ($0.01). The business had revenue of $797.40 million for the quarter, compared to the consensus estimate of $811.17 million. Bruker had a net margin of 2.31% and a return on equity of 17.89%. The business's revenue for the quarter was down .4% compared to the same quarter last year. During the same quarter last year, the firm posted $0.52 EPS. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. As a group, sell-side analysts forecast that Bruker Corporation will post 2.69 earnings per share for the current fiscal year.

Bruker Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 3rd. Shareholders of record on Tuesday, September 23rd will be paid a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Tuesday, September 23rd. Bruker's payout ratio is 38.46%.

Analyst Ratings Changes

Several research analysts have issued reports on BRKR shares. UBS Group lowered their price target on shares of Bruker from $57.00 to $45.00 and set a "neutral" rating for the company in a report on Thursday, May 8th. Barclays lowered their price target on shares of Bruker from $46.00 to $43.00 and set an "overweight" rating for the company in a report on Monday, August 4th. The Goldman Sachs Group lowered their price objective on shares of Bruker from $50.00 to $45.00 and set a "neutral" rating for the company in a research note on Thursday, May 8th. Wells Fargo & Company lowered their price objective on shares of Bruker from $60.00 to $50.00 and set an "overweight" rating for the company in a research note on Tuesday, August 5th. Finally, Bank of America lowered their price objective on shares of Bruker from $61.00 to $50.00 and set a "buy" rating for the company in a research note on Thursday, June 26th. Five research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, Bruker has a consensus rating of "Hold" and a consensus target price of $51.30.

Insider Buying and Selling

In other Bruker news, CEO Frank H. Laukien purchased 2,608 shares of the firm's stock in a transaction on Friday, June 6th. The stock was acquired at an average price of $38.36 per share, for a total transaction of $100,042.88. Following the purchase, the chief executive officer owned 38,462,171 shares of the company's stock, valued at $1,475,408,879.56. This trade represents a 0.01% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Company insiders own 27.30% of the company's stock.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.